BioCentury
ARTICLE | Company News

FDA approves Boehringer's Mobic for RA

August 9, 2004 7:00 AM UTC

FDA granted marketing approval for Mobic meloxicam from Boehringer Ingelheim (Ingleheim, Germany) to treat rheumatoid arthritis (RA). The NSAID already is approved to treat osteoarthritis. Mobic is co...